A detailed history of Royal Bank Of Canada transactions in Veru Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 19,664 shares of VERU stock, worth $12,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,664
Previous 18,424 6.73%
Holding current value
$12,388
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.04 $954 - $1,289
1,240 Added 6.73%
19,664 $15,000
Q2 2024

Aug 14, 2024

BUY
$0.76 - $1.79 $10,202 - $24,028
13,424 Added 268.48%
18,424 $15,000
Q1 2024

Nov 05, 2024

SELL
$0.37 - $0.72 $4,966 - $9,665
-13,424 Reduced 72.86%
5,000 $3,000
Q1 2024

May 15, 2024

SELL
$0.37 - $0.72 $314 - $612
-850 Reduced 14.53%
5,000 $3,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $425 - $742
635 Added 12.18%
5,850 $4,000
Q3 2023

Nov 14, 2023

BUY
$0.72 - $1.33 $982 - $1,815
1,365 Added 35.45%
5,215 $3,000
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.49 $7,286 - $11,078
-7,435 Reduced 65.88%
3,850 $4,000
Q1 2023

May 15, 2023

SELL
$1.16 - $6.41 $285,121 - $1.58 Million
-245,794 Reduced 95.61%
11,285 $13,000
Q4 2022

Feb 14, 2023

SELL
$4.78 - $15.01 $912,822 - $2.87 Million
-190,967 Reduced 42.62%
257,079 $1.36 Million
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $2.04 Million - $4.74 Million
200,028 Added 80.65%
448,046 $5.16 Million
Q2 2022

Aug 15, 2022

SELL
$4.35 - $15.85 $23,185 - $84,480
-5,330 Reduced 2.1%
248,018 $2.8 Million
Q1 2022

May 16, 2022

BUY
$4.55 - $6.41 $1.04 Million - $1.46 Million
227,506 Added 880.37%
253,348 $1.22 Million
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $35,793 - $59,129
6,077 Added 30.75%
25,842 $152,000
Q3 2021

Nov 15, 2021

BUY
$6.78 - $9.89 $43,886 - $64,017
6,473 Added 48.7%
19,765 $169,000
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $96,234 - $148,870
13,292 New
13,292 $107,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $50.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.